MX347956B - Abertura de anillo de lactonas y lactamas. - Google Patents
Abertura de anillo de lactonas y lactamas.Info
- Publication number
- MX347956B MX347956B MX2013009617A MX2013009617A MX347956B MX 347956 B MX347956 B MX 347956B MX 2013009617 A MX2013009617 A MX 2013009617A MX 2013009617 A MX2013009617 A MX 2013009617A MX 347956 B MX347956 B MX 347956B
- Authority
- MX
- Mexico
- Prior art keywords
- ring
- present
- lactams
- lactones
- ring opening
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
La presente invención proporciona un proceso novedoso para abrir un anillo de lactona y/o de lactama. De una manera más particular, la presente invención proporciona un proceso que emplea un catalizador novedoso en la abertura de un anillo de lactona y/o de un anillo de lactama. Adicionalmente, la presente invención también proporciona un proceso de desprotección novedoso de cualquier grupo protector presente ya sea en el compuesto que contiene anillo de lactona y/o que contiene anillo de lactama y/o en el producto de anillo abierto de los mismos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23288009P | 2009-08-11 | 2009-08-11 | |
US23288609P | 2009-08-11 | 2009-08-11 | |
PCT/US2010/045121 WO2011019789A1 (en) | 2009-08-11 | 2010-08-11 | The ring opening of lactones and lactams |
Publications (1)
Publication Number | Publication Date |
---|---|
MX347956B true MX347956B (es) | 2017-05-16 |
Family
ID=42813428
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013009617A MX347956B (es) | 2009-08-11 | 2010-08-11 | Abertura de anillo de lactonas y lactamas. |
MX2013009618A MX344328B (es) | 2009-08-11 | 2010-08-11 | Abertura de anillo de lactonas y lactamas. |
MX2012001850A MX2012001850A (es) | 2009-08-11 | 2010-08-11 | Abertura de anillo de lactonas y lactamas. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013009618A MX344328B (es) | 2009-08-11 | 2010-08-11 | Abertura de anillo de lactonas y lactamas. |
MX2012001850A MX2012001850A (es) | 2009-08-11 | 2010-08-11 | Abertura de anillo de lactonas y lactamas. |
Country Status (12)
Country | Link |
---|---|
US (1) | US8779198B2 (es) |
EP (1) | EP2464623B1 (es) |
JP (1) | JP5746696B2 (es) |
KR (1) | KR101755052B1 (es) |
CN (1) | CN102686556A (es) |
AU (1) | AU2010282623B2 (es) |
BR (1) | BR112012003255B1 (es) |
CA (1) | CA2769186C (es) |
IN (1) | IN2012DN00862A (es) |
MX (3) | MX347956B (es) |
RU (1) | RU2550691C2 (es) |
WO (1) | WO2011019789A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2551260A1 (en) | 2011-07-28 | 2013-01-30 | Chemo Ibérica, S.A. | Chemical process for opening ring compounds |
CN102351734B (zh) * | 2011-09-05 | 2014-02-26 | 浙江普洛医药科技有限公司 | 一种阿利克仑的制备方法 |
US8703976B2 (en) | 2011-10-02 | 2014-04-22 | Milan Soukup | Manufacturing process for 8-aryloctanoic acids such as Aliskiren |
CN108940117B (zh) * | 2018-08-03 | 2020-07-24 | 郑州轻工业学院 | 一种含羟基联接基团的非离子糖基型双子表面活性剂及其制备方法 |
CN110452231B (zh) * | 2019-08-16 | 2023-03-28 | 上海应用技术大学 | 一种色氨酸类化合物及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4729985A (en) * | 1985-08-09 | 1988-03-08 | Pfizer Inc. | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues |
FI870474A (fi) | 1986-02-07 | 1987-08-08 | Ciba Geigy Ag | Med svavelhaltiga grupper substituerade 5-amino-4-hydroxivalerylderivat. |
MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
US20060154926A1 (en) * | 2002-06-11 | 2006-07-13 | Elan Pharmaceuticals, Inc. | Methods of treating alzheimer's disease using aryl alkanoic acid amides |
US7582782B2 (en) | 2003-11-26 | 2009-09-01 | Novartis Ag | Organic compounds |
GB0419361D0 (en) * | 2004-08-31 | 2004-10-06 | Novartis Ag | Organic compounds |
GB0511686D0 (en) * | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
GB0521083D0 (en) * | 2005-10-17 | 2005-11-23 | Novartis Ag | Organic compounds |
GB0605780D0 (en) * | 2006-03-22 | 2006-05-03 | Syngenta Ltd | Formulations |
BRPI0809678A2 (pt) * | 2007-04-03 | 2014-10-07 | Novartis Ag | Métodos |
-
2010
- 2010-08-11 KR KR1020127006237A patent/KR101755052B1/ko active IP Right Grant
- 2010-08-11 IN IN862DEN2012 patent/IN2012DN00862A/en unknown
- 2010-08-11 CN CN2010800455933A patent/CN102686556A/zh active Pending
- 2010-08-11 CA CA2769186A patent/CA2769186C/en not_active Expired - Fee Related
- 2010-08-11 MX MX2013009617A patent/MX347956B/es unknown
- 2010-08-11 JP JP2012524828A patent/JP5746696B2/ja not_active Expired - Fee Related
- 2010-08-11 EP EP10744805.2A patent/EP2464623B1/en not_active Withdrawn - After Issue
- 2010-08-11 AU AU2010282623A patent/AU2010282623B2/en not_active Ceased
- 2010-08-11 RU RU2012108932/04A patent/RU2550691C2/ru active
- 2010-08-11 WO PCT/US2010/045121 patent/WO2011019789A1/en active Application Filing
- 2010-08-11 BR BR112012003255-0A patent/BR112012003255B1/pt not_active IP Right Cessation
- 2010-08-11 MX MX2013009618A patent/MX344328B/es unknown
- 2010-08-11 MX MX2012001850A patent/MX2012001850A/es active IP Right Grant
- 2010-08-11 US US13/389,849 patent/US8779198B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2012108932A (ru) | 2013-09-20 |
US8779198B2 (en) | 2014-07-15 |
RU2550691C2 (ru) | 2015-05-10 |
AU2010282623B2 (en) | 2013-12-12 |
EP2464623A1 (en) | 2012-06-20 |
KR20120054628A (ko) | 2012-05-30 |
MX344328B (es) | 2016-12-13 |
IN2012DN00862A (es) | 2015-07-10 |
CN102686556A (zh) | 2012-09-19 |
CA2769186C (en) | 2016-10-04 |
BR112012003255A8 (pt) | 2016-05-17 |
JP2013501797A (ja) | 2013-01-17 |
JP5746696B2 (ja) | 2015-07-08 |
KR101755052B1 (ko) | 2017-07-06 |
CA2769186A1 (en) | 2011-02-17 |
AU2010282623A1 (en) | 2012-02-23 |
BR112012003255A2 (pt) | 2016-03-01 |
BR112012003255B1 (pt) | 2018-10-23 |
WO2011019789A1 (en) | 2011-02-17 |
MX2012001850A (es) | 2012-03-07 |
US20120165555A1 (en) | 2012-06-28 |
EP2464623B1 (en) | 2020-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA110199C2 (en) | Solid rifaximin dispersion | |
TW200608973A (en) | Rapamycin polymorph Ⅱ and uses thereof | |
MX341825B (es) | Compuestos de heteroarilo y usos de los mismos. | |
MX2011002966A (es) | Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona). | |
TN2012000147A1 (en) | 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives | |
MX2012001850A (es) | Abertura de anillo de lactonas y lactamas. | |
WO2009135646A3 (en) | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale | |
MY140739A (en) | 2, 6-quinolinyl derivatives, processes for preparing them and their uses | |
UA105785C2 (uk) | Спосіб очищення ліпопептидів | |
IN2012DN05171A (es) | ||
HK1107354A1 (en) | INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6ß,7ß;15ß,16ß- BISMETHYLENE-3-OXO-17a-PREGN-4-ENE-21-CARBOXYLIC ACID GAMMA LACTONE AND KEY INTERMEDIATES FOR THIS PROCESS | |
TW200702331A (en) | Process for preparing alkylanilides | |
MX2007010143A (es) | Formas cristalinas de intermedio de linezolid. | |
MY151005A (en) | Amide compounds as boosters of antivirals | |
WO2009137714A3 (en) | Forms of lapatinib ditosylate and processes for preparation thereof | |
UA112752C2 (uk) | Лікарський засіб та метод блокування утворення або посилення знищення білка p24 | |
WO2010119450A3 (en) | An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts | |
WO2010059916A3 (en) | Preparation of docetaxel | |
MX2010002167A (es) | Medicamentos que contienen levaduras. | |
PL2091478T3 (pl) | Opakowanie prezerwatyw | |
HK1131156A1 (en) | Novel morphine derivatives | |
MX2009006748A (es) | Proceso para la preparacion y aislamiento de los estereoisomeros individuales de fenilciclopentan-carboxilatos 3-sustituidos de 1-amino. | |
MX2010003056A (es) | Polimorfos de valomaciclovir. | |
WO2010131118A3 (en) | Polymorphs of etravirine and processes for preparation thereof | |
SI2473492T1 (sl) | Postopek za pripravo(1S,4R)-2-oksa-3-azabiciklo(2.2.1)hept-5-enov |